Cole Schmidtknecht, 22, suffered from asthma, a chronic disease, that he treated with an Advair Diskus inhaler that allegedly cost him no more than $66. That cost changed last year when OptumRx ...

From birth, Cole Schmidtknecht suffered from chronic asthma that he treated with an Advair Diskus inhaler that cost him no more than $66. That changed last year when OptumRx, a subsidiary of ...

Though they fell short of the Hot 100's top spot, some No. 2 hits have generated cultural legacies that rival or even eclipse their chart-topping counterparts. By Trevor Anderson In his ...

The best things in life are free. Sign up for our email to enjoy your city without spending a thing (as well as some options when you’re feeling flush). Our newsletter hand-delivers the best ...

After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...

Schmidtknecht took daily doses of Advair Diskus to manage his asthma, the lawsuit said. His medication was covered by his employer-provided health insurance United Health-OptumRx Plan. Under the ...

“The VA inhaler formulary change was carried out at the VA to save money given similar clinical efficacy data for Symbicort and Wixela Inhub, but we’re very interested to know the impact that ...

Onchain data reveals that the number of Bitcoin wallets holding at least $100 is nearing all-time highs. According to Binance, the number of wallet addresses holding $100 or more surged from 24 ...

When customers choose our products, services and solutions today, they also gain 100 years of experience and expertise. Whether you’re a customer, an employee, a dealer, a supplier or simply a fan, ...

While Sandoz has emerged as the front-runner to get a generic version of GlaxoSmithKline’s respiratory blockbuster Advair to the US market, rival Hikma has not given up despite a major setback.